| |
|
|
|
Corvus Pharma Com  
|
|
4.13 -0.17 (-0.04%) |
09-22 16:00 |
|
Open: |
4.37 |
Pre close: |
4.3 |
Target:
|
5.73
|
|
High: |
4.37 |
Low: |
4.01 |
Resistance:
|
4.91
5.73
|
|
Volume: |
211,674 |
Market Cap: |
123M |
Support:
|
3.70
2.95
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.35
 |
MACD |
MACD(12,26):
|
0.12 |
|
MA(20): |
3.83  |
Signal(12,26,9): |
0.05 |
|
MA(100): |
3.68 |
Stochastic Oscillator |
%K(14,3):
|
68.54 |
|
MA(250): |
3.61 |
%D(3): |
73.02 |
|
Average Volume(K) |
3-Month: |
226442
|
52-Week |
High:
|
6.88 |
|
10-Days: |
54388 |
Low: |
1.01 |
|
RSI |
RSI(14):
|
54.06 |
Change(%): |
25.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.550 |
Return on Equity (ttm) |
-64.9 |
Shares Out. (M) |
28.04 |
|
EPS Est. Current Year |
-3.180 |
Return on Assets (ttm) |
-35.1 |
Shares Float (M) |
14.34 |
|
EPS Est. Next Year |
-3.410 |
PEG Ratio |
0.00 |
% Held by Insiders |
6.31 |
|
EPS Est. Next Quarter |
-0.840 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
75.64 |
|
Forward EPS |
-1.590 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1620 |
|
Book Value (p.s.) |
1.810 |
EBITDA (p.s.) |
-1.650 |
P/E |
-2.66 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.28 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-37.96 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-21.24 |
P/CF |
-3.05 |
|
|
|
|
|
|
